Guelrud M, Mendoza S, Rossiter G, Ramirez L, Barkin J
Gastroenterology Department, Hospital General de Oeste, MSAS, Los Magallanes, Caracas, Venezuela.
Gastroenterology. 1988 Oct;95(4):1050-5. doi: 10.1016/0016-5085(88)90182-5.
The effect of nifedipine on sphincter of Oddi (SO) motor activity was determined by endoscopic manometry. Sphincter of Oddi pressures and motor function were compared in 21 healthy volunteers and in 9 patients with SO dyskinesia. The effects of sublingual doses of 10 or 20 mg of nifedipine were compared with placebo. Neither placebo nor 10 mg of nifedipine produced any effect on SO motor activity. In healthy volunteers 20 mg of nifedipine produced a moderate but significant decrease in basal SO pressure from 12.0 to 6.7 mmHg as well as in the amplitude, duration, and frequency of phasic contractions. In patients with SO dyskinesia 20 mg of nifedipine also resulted in a significant but more profound decrease of the basal SO pressure from 47.1 to 17.3 mmHg as well as in a decrease of amplitude, duration, and frequency of the phasic contractions. Neither placebo nor 10 or 20 mg of nifedipine has any effect on the sequence of phasic contractions. In summary, nifedipine may have a possible therapeutic role in the treatment of SO dyskinesia.
通过内镜测压法确定硝苯地平对Oddi括约肌(SO)运动活性的影响。比较了21名健康志愿者和9名SO运动障碍患者的Oddi括约肌压力和运动功能。将舌下含服10毫克或20毫克硝苯地平的效果与安慰剂进行了比较。安慰剂和10毫克硝苯地平对SO运动活性均无任何影响。在健康志愿者中,20毫克硝苯地平使基础SO压力从12.0毫米汞柱适度但显著降低至6.7毫米汞柱,同时使相性收缩的幅度、持续时间和频率降低。在SO运动障碍患者中,20毫克硝苯地平也导致基础SO压力从47.1毫米汞柱显著但更明显地降低至17.3毫米汞柱,同时相性收缩的幅度、持续时间和频率也降低。安慰剂以及10毫克或20毫克硝苯地平对相性收缩序列均无任何影响。总之,硝苯地平在治疗SO运动障碍方面可能具有潜在的治疗作用。